GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » 6-1 Month Momentum %

HAEMATO AG (XTER:HAEK) 6-1 Month Momentum % : 11.67% (As of May. 12, 2024)


View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-12), HAEMATO AG's 6-1 Month Momentum % is 11.67%.

The industry rank for HAEMATO AG's 6-1 Month Momentum % or its related term are showing as below:

XTER:HAEK's 6-1 Month Momentum % is ranked worse than
83.02% of 1107 companies
in the Drug Manufacturers industry
Industry Median: 0.83 vs XTER:HAEK: 11.67

Competitive Comparison of HAEMATO AG's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HAEMATO AG's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's 6-1 Month Momentum % falls into.



HAEMATO AG  (XTER:HAEK) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HAEMATO AG  (XTER:HAEK) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


HAEMATO AG 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


HAEMATO AG (XTER:HAEK) Business Description

Traded in Other Exchanges
Address
Lilienthalstrasse 5c, Schonefeld, DEU, D-12529
HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines